Published in Am J Surg on September 11, 2008
Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol (2012) 1.69
Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc Intervent Radiol (2012) 1.29
Radiofrequency ablation vs hepatic resection for solitary colorectal liver metastasis: a meta-analysis. World J Gastroenterol (2011) 1.20
Radiofrequency ablation for treating liver metastases from a non-colorectal origin. Korean J Radiol (2011) 1.09
Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, the interventional oncology sans frontières meeting 2013. Eur Radiol (2015) 1.07
Comparative analysis of radiofrequency ablation and surgical resection for colorectal liver metastases. J Korean Surg Soc (2011) 1.04
Liver-directed therapies in metastatic colorectal cancer. J Gastrointest Oncol (2014) 0.97
Viable tumor tissue adherent to needle applicators after local ablation: a risk factor for local tumor progression. Ann Surg Oncol (2011) 0.96
Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer. J Cancer Res Clin Oncol (2011) 0.95
Comparative analysis of radiofrequency ablation and resection for resectable colorectal liver metastases. World J Gastroenterol (2014) 0.88
Minimally invasive local therapies for liver cancer. Cancer Biol Med (2014) 0.88
Thermal tumor ablation therapy for colorectal cancer hepatic metastasis. J Gastrointest Oncol (2012) 0.87
Does Radiofrequency Ablation Add to Chemotherapy for Unresectable Liver Metastases? Curr Colorectal Cancer Rep (2012) 0.86
Radiofrequency ablation as a treatment tool for liver metastases of colorectal origin. Cancer Imaging (2011) 0.86
Radiofrequency ablation versus resection for colorectal cancer liver metastases: a meta-analysis. PLoS One (2012) 0.83
Evaluation of YO-PRO-1 as an early marker of apoptosis following radiofrequency ablation of colon cancer liver metastases. Cytotechnology (2013) 0.82
Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer. World J Gastroenterol (2014) 0.82
Hepatectomy vs radiofrequency ablation for colorectal liver metastasis: a propensity score analysis. World J Gastroenterol (2015) 0.81
Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel. J Vasc Interv Radiol (2012) 0.80
Evolving ablative therapies for hepatic malignancy. Biomed Res Int (2014) 0.80
Clinical outcome of ultrasound-guided percutaneous microwave ablation on colorectal liver metastases. Oncol Lett (2014) 0.79
Changes in growth factor levels after thermal ablation in a murine model of colorectal liver metastases. HPB (Oxford) (2011) 0.79
Current strategies in interventional oncology of colorectal liver metastases. Br J Radiol (2016) 0.79
Commentary: Radiofrequency ablation for colorectal liver metastases: do not blame the biology when it is the technology. Am J Surg (2008) 0.78
Impact of treatment modality and number of lesions on recurrence and survival outcomes after treatment of colorectal cancer liver metastases. J Gastrointest Oncol (2014) 0.78
The role of radiofrequency ablation for treatment of metachronous isolated hepatic metastasis from colorectal cancer. Medicine (Baltimore) (2016) 0.77
Management of potentially resectable colorectal cancer liver metastases. World J Gastrointest Surg (2013) 0.77
Lack of Anatomical Concordance between Preablation and Postablation CT Images: A Risk Factor Related to Ablation Site Recurrence. Int J Hepatol (2012) 0.77
Surgical options for initially unresectable colorectal liver metastases. HPB Surg (2012) 0.77
Prognostic Factors in Terms of the Number of Metastatic Nodules in Patients With Colorectal Cancer Liver Metastases. Ann Coloproctol (2016) 0.77
Image-guided percutaneous ablation of hepatic malignancies. Semin Intervent Radiol (2014) 0.76
Comparison of Hepatic Resection and Radiofrequency Ablation for the Treatment of Colorectal Liver Metastasis. Indian J Surg (2015) 0.75
Imaging to optimize liver tumor ablation. Imaging Med (2010) 0.75
Radiofrequency ablation for liver metastases in patients with gastric cancer as an alternative to hepatic resection. BMC Cancer (2017) 0.75
Management of Hepatocellular Carcinoma in Cirrhotic Patients with Portal Hypertension: Relevance of Hagen-Poiseuille's Law. Liver Cancer (2014) 0.75
Radiofrequency Ablation versus Liver Resection for Colorectal Cancer Liver Metastasis: An Updated Systematic Review and Meta-analysis. Chin Med J (Engl) (2016) 0.75
Management of oligometastatic rectal cancer: is liver first? J Gastrointest Oncol (2015) 0.75
Irreversible electroporation in the treatment of locally advanced pancreas and liver metastases of colorectal carcinoma. Contemp Oncol (Pozn) (2016) 0.75
Hagen-Poiseuille's law: The link between cirrhosis, liver stiffness, portal hypertension and hepatic decompensation. World J Hepatol (2015) 0.75
A comparison of perioperative outcomes in elderly patients with malignant liver tumors undergoing laparoscopic liver resection versus radiofrequency ablation. Surg Endosc (2016) 0.75
Thermal Ablation in the Management of Colorectal Cancer Patients with Oligometastatic Liver Disease. Visc Med (2017) 0.75
Prognostic effect of perioperative change of serum carcinoembryonic antigen level: a useful tool for detection of systemic recurrence in rectal cancer. Ann Surg Oncol (2006) 2.62
Prognostic impact of inferior mesenteric artery lymph node metastasis in colorectal cancer. Ann Surg Oncol (2010) 2.35
Robotic versus laparoscopic low anterior resection of rectal cancer: short-term outcome of a prospective comparative study. Ann Surg Oncol (2009) 2.32
Multicenter analysis of risk factors for anastomotic leakage after laparoscopic rectal cancer excision: the Korean laparoscopic colorectal surgery study group. Ann Surg (2013) 2.08
Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int J Cancer (2007) 1.85
Risk factors for anastomotic leakage after laparoscopic intracorporeal colorectal anastomosis with a double stapling technique. J Am Coll Surg (2009) 1.83
Persistent hepatitis B viral replication affects recurrence of hepatocellular carcinoma after curative resection. Liver Int (2007) 1.80
VEGF-specific short hairpin RNA-expressing oncolytic adenovirus elicits potent inhibition of angiogenesis and tumor growth. Mol Ther (2007) 1.75
Totally robotic surgery for rectal cancer: from splenic flexure to pelvic floor in one setup. Surg Endosc (2009) 1.73
Robotic total mesorectal excision for rectal cancer using four robotic arms. Surg Endosc (2007) 1.68
Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis. Hepatology (2011) 1.67
A comparative study of voiding and sexual function after total mesorectal excision with autonomic nerve preservation for rectal cancer: laparoscopic versus robotic surgery. Ann Surg Oncol (2012) 1.67
Dynamic regulation of CFTR bicarbonate permeability by [Cl-]i and its role in pancreatic bicarbonate secretion. Gastroenterology (2010) 1.58
Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer. Eur Radiol (2012) 1.56
DNA methylation predicts recurrence from resected stage III proximal colon cancer. Cancer (2010) 1.55
Thymidylate synthase gene polymorphism affects the response to preoperative 5-fluorouracil chemoradiation therapy in patients with rectal cancer. Int J Radiat Oncol Biol Phys (2010) 1.52
Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis. Am J Gastroenterol (2006) 1.48
Assessment of sexual and voiding function after total mesorectal excision with pelvic autonomic nerve preservation in males with rectal cancer. Dis Colon Rectum (2002) 1.48
Colorectal flat neoplasia. Dig Liver Dis (2003) 1.43
[Assessment of the definition of early extrahepatic bile duct cancer through the prognosis analysis who had received curative resection]. Korean J Gastroenterol (2007) 1.43
MRI features of hepatocellular carcinoma expressing progenitor cell markers. Liver Int (2011) 1.42
Colonic ischemia following surgery for sigmoid colon and rectal cancer: a study of 10 cases and a review of the literature. Int J Colorectal Dis (2011) 1.42
Current status of liver diseases in Korea: hepatocellular carcinoma. Korean J Hepatol (2009) 1.42
Factors influencing pathologic results after total mesorectal excision for rectal cancer: analysis of consecutive 100 cases. Ann Surg Oncol (2007) 1.36
Solid pseudopapillary tumor of the pancreas suggesting malignant potential. Pancreas (2006) 1.31
Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis. J Hepatol (2010) 1.30
Frequent inactivation of SPARC by promoter hypermethylation in colon cancers. Int J Cancer (2007) 1.28
The use of adjusted preoperative CA 19-9 to predict the recurrence of resectable pancreatic cancer. J Surg Res (2007) 1.28
Intestinal endometriosis mimicking carcinoma of rectum and sigmoid colon: a report of five cases. Yonsei Med J (2009) 1.27
Outcome after curative resection for a huge (>or=10 cm) hepatocellular carcinoma and prognostic significance of gross tumor classification. Am J Surg (2009) 1.26
Isolated paraaortic lymph-node recurrence after the curative resection of colorectal carcinoma. J Surg Oncol (2008) 1.22
Oncologic outcomes of self-expanding metallic stent insertion as a bridge to surgery in the management of left-sided colon cancer obstruction: comparison with nonobstructing elective surgery. World J Surg (2009) 1.21
The impact of robotic surgery for mid and low rectal cancer: a case-matched analysis of a 3-arm comparison--open, laparoscopic, and robotic surgery. Ann Surg (2013) 1.19
Long-term oncologic outcomes of robotic low anterior resection for rectal cancer: a comparative study with laparoscopic surgery. Ann Surg (2015) 1.18
Long-term outcome of palliative therapy for malignant colorectal obstruction in patients with unresectable metastatic colorectal cancers: endoscopic stenting versus surgery. Gastrointest Endosc (2011) 1.16
Prognostic impact of the lymph node ratio in rectal cancer patients who underwent preoperative chemoradiation. J Surg Oncol (2011) 1.14
Early experiences of robotic-assisted laparoscopic liver resection. Yonsei Med J (2008) 1.13
Single-site versus conventional laparoscopic appendectomy: comparison of short-term operative outcomes. Surg Endosc (2010) 1.13
Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer. J Gastroenterol Hepatol (2006) 1.12
Laparoscopic-assisted versus open complete mesocolic excision and central vascular ligation for right-sided colon cancer. Ann Surg Oncol (2014) 1.12
Robotic liver resection: technique and results of 30 consecutive procedures. Surg Endosc (2012) 1.11
What is the best treatment modality for adrenal metastasis from hepatocellular carcinoma? J Surg Oncol (2007) 1.11
Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma. Eur J Nucl Med Mol Imaging (2003) 1.10
Patterns and relevant factors of tumor recurrence for extrahepatic bile duct carcinoma after radical resection. Hepatogastroenterology (2004) 1.10
Prediction of free bowel perforation in patients with intestinal Behçet's disease using clinical and colonoscopic findings. Dig Dis Sci (2010) 1.10
Surgical outcomes of hepatocellular carcinoma with bile duct tumor thrombus: a Korean multicenter study. World J Surg (2013) 1.08
The first korean experience of telemanipulative robot-assisted laparoscopic cholecystectomy using the da vinci system. Yonsei Med J (2007) 1.06
Robotic versus laparoscopic coloanal anastomosis with or without intersphincteric resection for rectal cancer. Surg Endosc (2013) 1.06
Clinicopathological characteristics in combined hepatocellular-cholangiocarcinoma: a single center study in Korea. Yonsei Med J (2011) 1.05
Insulin-secreting cells from human eyelid-derived stem cells alleviate type I diabetes in immunocompetent mice. Stem Cells (2009) 1.05
Inflammatory pseudotumor of the liver treated by hepatic resection: a case report. Yonsei Med J (2006) 1.04
Factors influencing recurrence after curative resection for ampulla of Vater carcinoma. J Surg Oncol (2007) 1.04
Colonic pseudoobstruction: CT findings. AJR Am J Roentgenol (2008) 1.04
Metastatic renal cell carcinoma of the gallbladder. Yonsei Med J (2003) 1.03
Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma. Eur J Cancer (2011) 1.03
Present status and perspectives of colorectal cancer in Asia: Colorectal Cancer Working Group report in 30th Asia-Pacific Cancer Conference. Jpn J Clin Oncol (2010) 1.03
The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection. J Surg Oncol (2009) 1.02
Accuracy in differentiation of mucinous and nonmucinous rectal carcinoma on MR imaging. J Comput Assist Tomogr (2003) 1.02
Prediction of microvascular invasion before curative resection of hepatocellular carcinoma. J Surg Oncol (2008) 1.02
Loss of E-cadherin and MUC2 expressions correlated with poor survival in patients with stages II and III colorectal carcinoma. Ann Surg Oncol (2010) 1.02